---
share: "true"
BOX:
  - ê°•ì˜ë¡
í•™ê¸°:
  - "08"
ê³¼ëª©:
  - ë‚´ê³¼í•™1
íŒ€í‹°ì¹­: í˜„ë‚´
ì°¨ì‹œ: 6-7ì£¼ì°¨
ì§„í–‰ë¥ : 
tags:
  - 08ì¤‘ê°„
ì§„í–‰ë„: 100%
share_link: https://share.note.sx/br6zi2hd#j30CuzCKOD1RI5ma0RTAJWxsvkbMV7bzXM+eXbVhiOo
share_updated: 2024-10-22T21:48:25+09:00
---
# Urinary tract infections (ë¹„ë‡¨ê¸°ê³„ ê°ì—¼ì¦)

â–¶ï¸ AIê°€ ë§Œë“¤ì–´ì¤€ [[UTI ë³µìŠµ í€´ì¦ˆ|UTI ë³µìŠµ í€´ì¦ˆ]]

# 1. Introduction

>[!check]- Urinary tract (ë¹„ë‡¨ê¸°ê³„)
>![[Urinary tract - í•´ë¶€í•™#Urinary tract(ë¹„ë‡¨ê¸°ê³„)ì˜ êµ¬ì„±|Urinary tract - í•´ë¶€í•™ > Urinary tract(ë¹„ë‡¨ê¸°ê³„)ì˜ êµ¬ì„±]]

## (1) Defense mechanisms of urinary tract

| Defense mechanism       |                                                                                                                                            |
| ----------------------- | ------------------------------------------------------------------------------------------------------------------------------------------ |
| Normal urination        | - Adequate flow<br>- Complete, frequent voiding (ë°°ë‡¨) : ì„¸ê·  ì •ì²´ ì—†ì´ ì œê±°                                                                         |
| Anatomical structures   | - **Lengt**h of urethra<br>- **Urethral high pressure** zone : ìš”ë„ê·¼ìœ„ë¶€ ì£¼ë¦„ íŒ½ì°½ìœ¼ë¡œ ì••ë ¥ ìƒìŠ¹<br>- Urethral peristalsis                               |
| Antimicrobial urine     | - **High urea content**<br>- **Low urine pH** : ê·  ì„±ì¥ ì–µì œ<br>- **Osmolarity**<br>- Organic acids<br>- Tamm-Horsfall protein                  |
| Mucosal defence barrier | - **Balanced distal urethra microflora**<br>- **Surface IgA antibodies**<br>- Glycosaminoglycan layer<br>- Exfoliation of urothelial cells |
- ì´ëŸ¬í•œ ë°©ì–´ ì²´ê³„ê°€ ê¹¨ì§€ë©´ ê°ì—¼ì— ì·¨ì•½í•´ì§.
## (2) Definition

- ì™¸ë¶€ í™˜ê²½ì—ì„œ bacteriaê°€ urethra(ìš”ë„)ë¡œ ë“¤ì–´ê°€, ì‹ ì²´ì˜ ë©´ì—­ ë°©ì–´ ì²´ê³„ë¥¼ ê¹¨ëœ¨ë¦¬ê³  uniray tract(ë¹„ë‡¨ê¸°ê³„)ì— ê°ì—¼ì„ ìœ ë°œí•œ ìƒíƒœ.<br>(Conditions that happen when bacteria from the external environment enter the urethra, evade the body's immune defenses and cause urinary tract infection)

![[Pasted image 20241016140116.png|250]]

| UPPER urinary tract infection (ìš”ê´€) |                       |
| ---------------------------------- | --------------------- |
| Kidney infection                   | Pyelonephritis (ì‹ ìš°ì‹ ì—¼) |
| Ureter infection : ë‹¨ë… ë°œìƒ ì ìŒ        | Ureteritis (ìš”ê´€ì—¼)      |

| **LOWER urinary tract infection (ìš”ë„)** |                    |
| -------------------------------------- | ------------------ |
| Bladder infection : ì••ë„ì ìœ¼ë¡œ ë§ìŒ           | **Cystitis (ë°©ê´‘ì—¼)** |
| Urethra infection : ë‹¨ë… ë°œìƒ ì ìŒ           | Urethritis (ìš”ë„ì—¼)   |

## (3) Predisposition, incidence, risk factor
- **ê°œ**ì—ì„œëŠ” **5-27%** ë¡œ í”í•¨ / ê³ ì–‘ì´ì—ì„œëŠ” <2%

| ê°œì—ì„œì˜ predisposition & incidence                           |
| --------------------------------------------------------- |
| Female > Male                                             |
| 2ì‚´ ì´í•˜ë‚˜ 6ì‚´ ì´ìƒì—ì„œ ë§ì´ ë°œìƒ                                      |
| í˜¸ë°œ í’ˆì¢…ì€ ë”°ë¡œ ì—†ìŒ                                              |
| DM(Diabetes mellitus) ë˜ëŠ” hyperadrenocorticism í™˜ìì˜ 41.6%ì—ì„œ |
| Long-term glucocorticoids ì ìš© ì‹œ 18-39%ì—ì„œ                   |
| **ê³ ì–‘ì´ì—ì„œëŠ”..**                                              |
| 10ì‚´ ì´ìƒì—ì„œ ë§ì´ ë°œìƒ                                            |
| Risk factor : Persian í’ˆì¢…, females, ë‚˜ì´ë“¦, ì²´ì¤‘ ê°ì†Œ             |
| í˜¹ì€ ì–´ë¦° ë‚˜ì´ì—ë„ ìš”ë¡œê³„ ìê·¹ì´ ì§€ì†ë˜ë©´ ë°œë³‘ ê°€ëŠ¥ (ìš”ì¹´í…Œí„°, ìˆ˜ìˆ  ë“±)                |
| CKDì˜ 17-30%, DMì˜ 12-13%, Hyperthyroidismì˜ 12-22%ì—ì„œ        |
>[!tldr]- Uropathogens (ê°ì—¼ì²´)
> - ì•„ë˜ 10ê°€ì§€ê°€ ê°œì—ì„œ UTI ê°ì—¼ì˜ 95-97%ë¥¼ ì°¨ì§€
> 	- ***Escherichia coli*** (50%)
> 	- *Staphylococcus*, *Streptococcus*, *Enterococcus* : ê·¸ëŒì–‘ì„±ê· 
> 	- *Proteus*, *Klebsiella*, *Pasteurella*, *Enterobacter*, *Pseudomonas*
> 	- *Mycoplasma*
> - ê³ ì–‘ì´ì—ì„œëŠ”..
> 	- ***Escherichia coli*** (47%)
> 	- *Staphylococcus* (18%)
> 	- *Streptococcus* (13%)
> 	- *Klebsiella* (4%)
> - ë‹¨ì¼ ê°ì—¼ì´ ê°€ì¥ í”í•¨(75%)
> - female dogsì—ì„œ multiple organism infectionì´ í”íˆ ê´€ì°°ë¨.

# 2. ë¶„ë¥˜
## (1) Classification of Bacterial cystitis (ì„¸ê· ì„± ë°©ê´‘ì—¼ì˜ ë¶„ë¥˜)

> - **Uncomplicated UTI** = **Sporadic bacterial cystitis** (ì‚°ë°œì„± ì„¸ê· ì„± ë°©ê´‘ì—¼) : ê±´ê°•í•œ ê°œì²´ì—ì„œ ì‚°ë°œì /ì¼ì‹œì ìœ¼ë¡œ ë°œìƒ
> - **Complicated UTI** : ì§€ì†ì , ì¬ë°œì„± ê°ì—¼, ì¹˜ë£Œ ì‹¤íŒ¨ë¡œ ì´ì–´ì§ˆ ìˆ˜ ìˆìŒ.
> 	- **Recurrent UTI** : 1ë…„ ë™ì•ˆ 3íšŒ ì´ìƒ ì¬ë°œ
> 		- ==**Relapsing** (ì¬ë°œ) : ì™„ì „íˆ ì¹˜ë£Œë˜ì—ˆëŠ”ë°, ë˜‘ê°™ì€ ê°ì—¼ì²´ì— ì˜í•´ ì¬ë°œ (ê°ì—¼ì›ì˜ ì”ì¡´)==
> 		- **Persistent** (ì§€ì†ê°ì—¼) : ì¹˜ë£Œí–ˆìœ¼ë‚˜, ì§€ì†ì ìœ¼ë¡œ ì„¸ê·  ê´€ì°°ë¨ (ìˆ™ì£¼ ë©´ì—­ ë¬¸ì œ, í•­ìƒì œ ë‚´ì„±ê· )
> 		- **Reinfection** (ì¬ê°ì—¼) : ìƒˆë¡œìš´ ê°ì—¼ì²´ì— ì˜í•´ ìœ ë°œ 
> 		- **Refractory** : ì¹˜ë£Œ ë°˜ì‘ ì—†ìŒ - ì¦ìƒ ê°œì„  X, ì„¸ê·  ì‚¬ë©¸ X
> - **Subclinical bacteriuria** (asymptomatic bacteriuria) : ì„ìƒì¦ìƒ(LUTS, lower urinary tract signs)ì€ ì—†ì§€ë§Œ ê·  ê²€ì¶œ

>[!tldr] Complicated UTIì˜ ìš”ì¸
> - í•´ë¶€í•™ì  ìš”ì¸ : ectopic ureters(ì´ì†Œì„± ìš”ê´€), ureteroceles(ìš”ê´€ë¥˜)
> - ì „ì‹  ì§ˆí™˜ : DM, hyperthyroidism, HAC(ë¶€ì‹ í”¼ì§ˆê¸°ëŠ¥í•­ì§„ì¦), systemic neoplasia, immunocompromised(ë©´ì—­ì €í•˜)
> - ë¹„ë‡¨ê¸°ê³„ ìì²´ ë¬¸ì œ : urolithiasis(ìš”ë¡œê²°ì„), cystic neoplasia(ë°©ê´‘ì¢…ì–‘), deep seated bacterial cystitis(ì‹¬ì¸µ ì„¸ê· ì„± ë°©ê´‘ì—¼)

## ğŸŸ¡ Pyelonephritis (ì‹ ìš°ì‹ ì—¼)

- **Acute pyelonephritis (APN)** : ë³´í†µ ì„¸ê· ì´ í•˜ë¶€ ìš”ë¡œì—ì„œ ì½©íŒ¥ê¹”ë•Œê¸°(renal pelvis), ì½©íŒ¥ ì‹¤ì§ˆ(parenchyma)ë¡œ ì˜¬ë¼ê°€ë©´ì„œ ë°œìƒ. ë©°ì¹ ~ëª‡ ì£¼ ë‚´ë¡œ ë°œë³‘. ê°€ë” í˜ˆí–‰ì„±(hematogenous)ìœ¼ë¡œë„ ë°œìƒí•¨.
	- **Complicated APN** : DM, ì¢…ì–‘, ë©´ì—­ì €í•˜, í•´ë¶€í•™ì  ë¬¸ì œ ë“± ì „ì‹  ì§ˆí™˜ê³¼ í•¨ê»˜ ë‚˜íƒ€ë‚˜ëŠ” ê²½ìš°
	- **Noncomplicated APN** <br>

![[Pasted image 20241016191119.png|250]]
## ğŸŸ¡ Bacterial prostatitis (ì„¸ê· ì„± ì „ë¦½ì„ ì—¼)
- ì„±ìˆ™í•œ ìˆ˜ì»· ê°œì—ì„œ ì£¼ë¡œ ë°œìƒí•˜ë©°, ë§Œì„± ë˜ëŠ” ê¸‰ì„±ìœ¼ë¡œ ë‚˜íƒ€ë‚¨.
	- Bacterial cystitisë„ í•¨ê»˜ ë™ë°˜í•  ë•Œê°€ ë§ìŒ.
	- ì „ë¦½ì„  ë†ì–‘ìœ¼ë¡œ ì§„í–‰ë˜ë©´ íŒŒì—´ê³¼ ê°™ì€ ì‹¬ê°í•œ ì§ˆë³‘ì„ ì´ˆë˜í•  ìˆ˜ ìˆìŒ.

>[!check] DDx for Bacterial prostatitis
>- Prostatic neoplasia (ì „ë¦½ì„  ì¢…ì–‘)
>- Prostatic cyst (ì „ë¦½ì„± ë‚­ì¢…) 
>- Prostatic hyperplasia (ì „ë¦½ì„  ë¹„ëŒ€ì¦) 
>- Perirectal mass (ì§ì¥ì£¼ìœ„ ì¢…ì–‘)
>- Periprostatic mass (ì „ë¦½ì„ ì£¼ìœ„ ì¢…ì–‘)
>- Disease causing tenesmus (ì´ê¸‰í›„ì¦; í•­ë¬¸ ë¶ˆì™„ì „ ë°°ë³€ê° ìœ ë°œ ì§ˆí™˜)<br>  - e.g) large intestinal disease


# 3. ì„ìƒì  íŠ¹ì§•

- ë°©ê´‘ì—¼ì—ì„œ ì¼ë°˜ì ì¸ ì¦ìƒ
	- Typical **LUTS (lower urinary tract signs)** : stranguria(í†µì¦ë°°ë‡¨), hematuria(í˜ˆë‡¨), pollakuira(ë¹ˆë‡¨), periuria(ì´ìƒë°°ë‡¨; ë‹¤ë¥¸ ê³³ì— ì†Œë³€), dysuria(ë°°ë‡¨í†µ)
	- ì–´ë¦° ê³ ì–‘ì´ì˜ ê²½ìš° feline idiopathic cystitis ë¨¼ì € ì˜ì‹¬
	- **Excessive licking** (ê³¼ë„í•œ í•¥ìŒ) 
- ê¸‰ì„± ì‹ ìš°ì‹ ì—¼(APN)ì—ì„œ ì˜ ë‚˜íƒ€ë‚˜ëŠ” ì¦ìƒ
	- ë°œì—´, ì‹ìš•ë¶€ì§„, ê¸°ë ¥ì €í•˜, êµ¬í†  + **PUPD**(ë‹¤ìŒë‹¤ë‡¨)
- ê¸‰ì„± ì „ë¦½ì„ ì—¼(acute prostatitis)ì—ì„œ ì˜ ë‚˜íƒ€ë‚˜ëŠ” ì¦ìƒ
	- **Purulent/hemorrhagic urethral disharge** (í™”ë†ì„±, ì¶œí˜ˆì„± ìš”ë„ ë¶„ë¹„ë¬¼)
	- ë°œì—´, ì‹ìš•ë¶€ì§„, ê¸°ë ¥ì €í•˜, êµ¬í†  + **preputial edema, hindlimb edema, tenesmus**(ì´ê¸‰í›„ì¦)
- Abdominal pain(ë³µë¶€ í†µì¦)ë„ ë‚˜íƒ€ë‚  ìˆ˜ ìˆìŒ


# 4. ì§„ë‹¨

| ê¸°ì¤€                   |                                                                                   |
| -------------------- | --------------------------------------------------------------------------------- |
| **Signalment**           | - APN(ê¸‰ì„±ì‹ ìš°ì‹ ì—¼) : Boxer<br>- Prostatitis(ì „ë¦½ì„ ì—½) : ì„±ìˆ™ ìˆ˜ì»·, í‰ê·  7-11ì„¸                    |
| **ë¬¸ì§„ ì²­ì·¨**                | ê¸°ì €ì§ˆí™˜ ìœ ë¬´, ì¬ë°œ ì—¬ë¶€ ë“±                                                                  |
| **ì‹ ì²´ ê²€ì‚¬**                | ë³µë¶€ ì´‰ì§„, ì§ì¥ ì´‰ì§„, í”¼ë¶€ ê²€ì‚¬, digital vaginal ê²€ì‚¬ (ì§ˆ, ì™¸ìŒë¶€ ê°ì—¼ ìˆëŠ”ì§€)                           |
| - cycstitis (ë°©ê´‘ì—¼)    | - ì‘ê³ , ë¹ˆ ë°©ê´‘ / ë°©ê´‘ë²½ ë¹„í›„ (\*ë“œë¬¼ê²Œ ê²°ì„, ì¢…ì–‘ ë“±ìœ¼ë¡œ ë°©ê´‘ ë¹„ëŒ€)<br>- caudal abdominal or lumpar pain |
| - APN (ê¸‰ì„± ì‹ ìš°ì‹ ì—¼)      | - flank, abdominal, sublumbar pain<br>- kidney failure(ì‹ ë¶€ì „)ìœ¼ë¡œ ë°œì „í•  ê°€ëŠ¥ì„±             |
| - Prostatitis (ì „ë¦½ì„ ì—¼) | - ì „ë¦½ì„ ì˜ ë¹„ëŒ€ì¹­ í™•ì¥, ê³ í†µ (\*ë“œë¬¼ê²Œ ì–‘ì¸¡ì„±, ë¹„ëŒ€ë˜ì§€ ì•Šì„ ìˆ˜ ìˆìŒ)<br>- preputial, hindlimb edema        |


| Urinalysis             |                                                                                                                                                                                       |
| ---------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **ë¬¼ë¦¬ì  ê²€ì‚¬**             | - í˜ˆë‡¨ and/or ë†ë‡¨<br>- USG(ìš”ë¹„ì¤‘)ì˜ variationì´ í¼<br>![[Pasted image 20241017005417.png\|320]]                                                                                               |
| **í™”í•™ì  ë¶„ì„**             | - Dip-stickì—ì„œ í˜ˆë‡¨, ë‹¨ë°±ë‡¨                                                                                                                                                                 |
| **UPC ratio**          | - ì‹¬í•œ ë‹¨ë°±ë‡¨ê°€ í™•ì¸ëœ ê²½ìš° ì„ íƒì ìœ¼ë¡œ                                                                                                                                                                |
| **ì¹¨ì „ë¬¼ ê²€ì‚¬<br>(ìš”ì¹¨ì‚¬ ê²€ì‚¬)** | - ì—¼ì¦ ì„¸í¬ : **>5 WBC**/400ë°° ì‹œì•¼<br>- ì„¸ê·  í™•ì¸ : ìˆ˜, ëª¨ì–‘, intra/extracellular, phagocytosis í™•ì¸ ë“±<br>- Wet ê²€ì‚¬ â†’ ê²°ì„, dryì—ì„œ í™•ì¸ë˜ì§€ ì•Šì€ ì´ìƒ ì„¸í¬, RBC ì‚°ì¬ ì •ë„<br>![[Pasted image 20241022165737.png\|550]] |


| **Urine culture**                         | \* ë°°ì–‘ ì˜ë¢° ì „ 3-5ì¼ê°„ í•­ìƒì œ ì²˜ì¹˜ ì¤‘ë‹¨                                                                                                                                                                                                                            |
| ----------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Indications<br>(ê¶Œì¥ë˜ëŠ” ìƒí™©)                  | - ê²½í—˜ì (empiric) ì¹˜ë£Œë¡œ ê°œì„ ë˜ì§€ ì•ŠìŒ<br>- ì¬ë°œì„±(recurrent) UTIs<br>- ê¸‰ì„± ì‹ ìš°ì‹ ì—¼(APN) : Nephropyelocentesis(ì‹ ìš°ì²œì), blood culture ê³ ë ¤<br>- ê¸‰ì„± ì „ë¦½ì„ ì—¼ : Prostate culture ê³ ë ¤ (ëŒ€ë¶€ë¶„ ë°©ê´‘ì²œìì—ì„œ ì°¾ì•„ì§€ê¸´ í•¨)                                                                            |
| Urine sampling & handling<br>(ì†Œë³€ì˜ ì±„ì·¨ì™€ ì·¨ê¸‰) | - ê°€ì¥ ì´ìƒì ì¸ ì±„ì·¨ : **cystocentesis** (ë°©ê´‘ ì²œì)<br>   - ë“œë¬¼ê²Œ urethral catheterization(ì¹´í…Œí„° ì‚¬ìš©)ìœ¼ë¡œ ëŒ€ì²´<br>- ì´ìƒì ì¸ ë³´ê´€ : **UTT** (urine culture transport tubes) + preservative (ë³´ì¡´ì œ)<br>   - 24ì‹œê°„ ë‚´ ì‹¤í—˜ì‹¤ ìˆ˜ì†¡ ê¶Œì¥ (ë³´ì¡´ì œ ìˆì–´ë„ <48H)<br>   - ê¸°ë³¸ ìš”ê²€ì‚¬ëŠ” ë³´ì¡´ì œ ì—†ì´ syringe ë³´ê´€í•´ë„ ë¨. |
| Susceptibility testing<br>(í•­ìƒì œ ê°ìˆ˜ì„± ê²€ì‚¬)    | - '<u>í˜ˆì²­ í•­ìƒì œ ë†ë„</u>'ê°€ ê¸°ì¤€ ('ì†Œë³€ í•­ìƒì œ ë†ë„'ì™€ëŠ” ìƒì´í•  ìˆ˜ ìˆìŒ)<br>- ë‘ ê°€ì§€ ì´ìƒì´ ë‚˜ì˜¤ë©´ ê° ì„¸ê· ì— ëŒ€í•œ í…ŒìŠ¤íŠ¸ ë‹¤ì‹œ ì‹¤ì‹œ<br>- ì†Œë³€ìœ¼ë¡œ ì£¼ë¡œ ë°°ì„¤ë˜ëŠ” í•­ìƒì œì˜ ê²½ìš°, ë‚´ì„±ì´ ìˆë”ë¼ë„ íš¨ê³¼ ìˆì„ ìˆ˜ ìˆìŒ<br>   â†’ í•­ìƒì œ ì•½ë¬¼ì˜ ëŒ€ì‚¬ ê²½ë¡œì— ë”°ë¼ UTIì— ë§ëŠ” í•­ìƒì œë¥¼ ì‚¬ìš©í•  ìˆ˜ë„ ìˆìŒ                                                                |
| ê²°ê³¼ í•´ì„                                     | - **Susceptible** : í•­ìƒì œ ì¹˜ë£Œ ê°€ëŠ¥<br>- **Intermittent** : ê°€ëŠ¥í•  ìˆ˜ë„ ìˆìŒ (ë„“ì€ ë²”ìœ„ë¡œëŠ” resistant í•´ë‹¹)<br>- **Resistant** : ì¹˜ë£Œ íš¨ê³¼ ì—†ì„ ê²ƒ<br> â€» ë‹¨, ì‹¤í—˜ì‹¤ ê²€ì‚¬(*in vitro* culture)ì™€ ì„ìƒ ê²°ê³¼(*in vivo* efficacy)ëŠ” ë‹¤ë¥¼ ìˆ˜ ìˆìŒ!                                                       |

| Routine laboratory tests  |                                                                                                                                                                                                        |
| ------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| CBC                       | - **Leukocytosis** (Neutrophilic leukocytosis with a left shift)<br>   - uncomplicated(ì›ë°œì„±)ì™€ ë‹¬ë¦¬, complicated UTIì—ì„œëŠ” í˜ˆì•¡í•™ì  ë³€í™” ê°€ëŠ¥ì„±<br>   - ê¸°ì €ì§ˆí™˜, í•­ì•”ì¹˜ë£Œ, ë©´ì—­ë ¥ ì €í•˜ ë“±ìœ¼ë¡œ ì¸í•´<br>   - ë˜ëŠ” ì‹ ìš°ì‹ ì—¼/ì „ë¦½ì„ ì—¼ì„ ë™ë°˜í•  ë•Œ, ì „ì‹ ê°ì—¼ì¼ ë•Œ |
| Serum biochemical profile | - **Renal azotemia**<br>   - ë§Œì„± ì‹ ìš°ì‹ ì—¼ì€ ì‹ ì¥ì„ ì†ìƒì‹œí‚´ â†’ azotemia, ê³ ì¸ì‚°í˜ˆì¦ ë“±                                                                                                                                     |
### Imaging (ì˜ìƒ ì§„ë‹¨)

| Radiographs _Cystitis                     |                                                    |
| ----------------------------------------- | -------------------------------------------------- |
| ![[Pasted image 20241022192335.png\|400]] | - ì‘ì€ í¬ê¸°ì˜ ë°©ê´‘<br>- ë°©ê´‘ë²½ì˜ ë¹„í›„(thickening), irregularity |

| Ultrasonography (Abd) _Cystitis                                                      |                                                                                                                                                                                |
| ------------------------------------------------------------------------------------ | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| ![[Pasted image 20241022193832.png\|270]]                                            | - ë°©ê´‘ë²½ ë¹„í›„, ìš°ë‘˜íˆ¬ë‘˜(âˆµì¢…ì–‘, polyp)<br>- ë°©ê´‘ ë‚´ê°•ì˜ Echogenic sediment<br><br>![[Pasted image 20241022190914.png\|200]]<br>+ Cystocopy(ë°©ê´‘ë‚´ì‹œê²½) : ìš”ë„ â†’ ë°©ê´‘ ë‚´ë¶€<br>   ê°ì—¼ í™•ë¥  ì¡´ì¬                   |
| **Emphysematous cystitis**<br>(ê¸°ì¢…ì„± ë°©ê´‘ì—¼)<br>![[Pasted image 20241017011128.png\|300]] | - Complicatted UTI, ë‹¹ë‡¨ í™˜ìì—ì„œ ì¢…ì¢… ë°œë³‘<br>- gas-producing bacteriaê°€ ë°©ê´‘ ë²½&ë‚´ê°•ì— gas accumulation<br>   - E. coli, Clostridium ë“±<br>- DM í™˜ìì—ì„œ 33, ì‹ ê²½ ì§ˆí™˜ í™˜ìì—ì„œ 26%, ë¶€ì‹  ì§ˆí™˜ í™˜ìì—ì„œ 19% ë°œìƒ<br> |



| Contrast radiography _Pyelonephritis      | (contrast = ì¡°ì˜ì œ ì‚¬ìš©)                                                           |
| ----------------------------------------- | ----------------------------------------------------------------------------- |
| ![[Pasted image 20241022192700.png\|300]] | - Mild to moderate pyelectasia (ì‹ ìš°í™•ì¥)<br>- Distortion of renal pelvis (ì‹ ìš° ë³€í˜•) |

| Ultrasonography (Abd)                     |  _Pyelonephritis                                                                                                                                                                                                                                                                                       |
| ----------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| ![[Pasted image 20241022193708.png\|300]] | - ëŒ€í‘œì ìœ¼ë¡œ ì¼ì‹œì ì¸ **ì½©íŒ¥ ë¹„ëŒ€** (renal pelvic dilation) <br>- Ureteral dilation (ìš”ê´€ í™•ì¥)<br>- Blunting of the renal papilla (ì½©íŒ¥ìœ ë‘ì˜ ë‘”í™”)<br>- Echogenic debris (ë‚´ë¶€ì— ê³ ì—ì½”ì„± ì”í•´)<br><br>\* ì‹ ìš°ì‹ ì—¼ì¸ë° ì½©íŒ¥ì´ ì¶•ì†Œë˜ì–´ ìˆìœ¼ë©´, CKDë‚˜ ë§Œì„± ì‹ ìš°ì‹ ì—¼ì„ ì˜ì‹¬í•´ë³´ì.<br><br>+ Bacterial culture : pyelocentesis(ì‹ ìš°ì²œì)ëŠ” ì‹¤ì§ˆì„ ê±´ë“œë¦´ ìˆ˜ ìˆìœ¼ë‹ˆ, ë°©ê´‘ samplingë¶€í„° ì‹œë„ |


| Contrast radiographs _Prostatitis         |                            |
| ----------------------------------------- | -------------------------- |
| ![[Pasted image 20241016112807.png\|250]] | - ì „ë¦½ì„  ë¹„ëŒ€<br>- ë†ì–‘<br>- ë°°ë‡¨ê³¤ë€ |

| Ultrasonography (Abd)                     |  _Prostatitis                                                                                                                                       |
| ----------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- |
| ![[Pasted image 20241022194855.png\|300]] | - ì „ë¦½ì„ ì˜ ë¹„ëŒ€ì™€ mildí•œ hyperechogenecityë¶€í„°,<br>- ì‹¬ê°í•œ ë¹„ëŒ€ì™€ **mottled** hyperechoic~hypoechoic pattern (ì–¼ë£©ëœë£©í•œ íŒ¨í„´) ê¹Œì§€ ë‹¤ì–‘í•¨.<br>   - mottled sign â†’ ê°ì—¼, ì¢…ì–‘ ìˆì„ ë•Œ |

# 5. ì¹˜ë£Œ
- ë°©ê´‘ ì¢…ì–‘, í˜¸ë¥´ëª¬ ì§ˆí™˜ ë“± ê¸°ì €ì§ˆí™˜ì„ ë°°ì œí•˜ê³  ì‹œì‘. (í˜¹ì€ ê°™ì´ ê´€ë¦¬)
- ìŠ¤í…Œë¡œì´ë“œ/ë©´ì—­ì–µì œ ì•½ë¬¼ì„ ì‚¬ìš©í•˜ëŠ” í™˜ìì—ì„œ, ë¹„ë‡¨ê¸°ê³„ì™€ í”¼ë¶€ ê°ì—¼ì— ì·¨ì•½.
- í•­ìƒì œ ê°ìˆ˜ì„± ê²€ì‚¬ í›„ì— ì²˜ë°©í•˜ëŠ” ê²ƒì´ ë°”ëŒì§.
- ì´ˆê¸°ì—ëŠ” í•­ìƒì œë³´ë‹¤ ==ì§„í†µì œ== ì²˜ë°© ê¶Œì¥
	- e.g. <span style="background:#faeab0"><b>NSAIDs</b></span>  - ë‹¨ ì‹ ë…ì„± ì¡´ì¬, ìœ ì˜í•´ì„œ ì²˜ë°©.
### âœ… Subclinical bacteriuria
- ì„ìƒ ì¦ìƒì€ ì—†ì§€ë§Œ ê· ì´ ë°©ì¶œë¨. ì•„ë˜ì™€ ê°™ì€ ê²½ìš° ì˜ ë‚˜íƒ€ë‚¨.
	- ê¸°ì € ì§ˆí™˜ì´ ìˆëŠ” ê²½ìš° - ë‚´ë¶„ë¹„ ì§ˆí™˜, ì‹ ì¥ ì§ˆí™˜, ë°°ë‡¨ ì¥ì• (micturition disorders) ë“±
	- gluticorticoids, immunosuppressive ì•½ë¬¼ ë³µìš© ì‹œ
	- íšŒìŒë¶€ ìš”ë„ ì ˆê°œìˆ (perineal urethrostomies) ì‹¤ì‹œ â†’ ìš”ë„ ì§§ì•„ì ¸ ê°ì—¼ë¥  ë†’ì•„ì§.
- <span style="background:#faeab0">ë¶ˆí•„ìš”í•œ í•­ìƒì œ ì²˜ë°©ë³´ë‹¤ëŠ”, <u>ëª¨ë‹ˆí„°ë§ì´ ê¶Œì¥ë¨</u>.</span>

### âœ… Uncomplicate UTI
- ISCAID ê°€ì´ë“œë¼ì¸ : 5-7ì¼ í•­ìƒì œ ì¹˜ë£Œ
- ì í•©í•œ í•­ìƒì œë¥¼ ì²˜ë°©í•˜ë©´ ì´í‹€ ì•ˆì— ì¦ìƒì´ ê°œì„ ë¨.
	- ì†Œë³€ ë‚´ì—ì„œì˜ ì„¸ê·  ê°œì„ ë„ 3-5ì¼ ë‚´ì— ì´ë£¨ì–´ì§.
	- ì´ ê°œì„ ì´ ë³´ì´ì§€ ì•Šìœ¼ë©´ complicate UTIê±°ë‚˜, í•­ìƒì œë¥¼ ì˜ëª» ì¼ê±°ë‚˜.
- ë°©ê´‘ì—¼ í™˜ìì—ì„œ í•˜ë£¨ 1ë²ˆ ì•½ì„ ë¨¹ì´ëŠ” ê²½ìš°, ì €ë…ì— ë¨¹ì´ëŠ” ê²ƒì„ ê¶Œì¥í•¨. (ìˆ˜ë©´ ì‹œê°„ ë™ì•ˆ ì¶©ë¶„íˆ ì•½ë¬¼ ì‘ìš©í•  ìˆ˜ ìˆë„ë¡)
<br>
- ê²½í—˜ì  í•­ìƒì œë¥¼ ìš°ì„  ì²˜ë°©í•´ì•¼ í•˜ëŠ” ìƒí™©ë„ ìˆìŒ. (í•­ìƒì œ ë‚´ì„± ê²€ì‚¬ë¥¼ ê±°ë¶€í•  ë•Œ)
- Cytology â†’ ê°„ê· , ë‹¨ê°„ê· ì´ ë‹¤ìˆ˜ ê´€ì°°ëœë‹¤

| Cytology                                  |                                          |                                                |                                                          |
| ----------------------------------------- | ---------------------------------------- | ---------------------------------------------- | -------------------------------------------------------- |
| Gram (-)<br>==ê°„ê· ==(rod),<br>ë‹¨ê°„ê· (bacillus) | ![[Pasted image 20241022200302.png\|80]] | **Cephalosporins**<br>ìš°ì„ ì ìœ¼ë¡œ ê³ ë ¤                 | ==E. coli, Enterobacter, <br>Klebsiella, Proteus==, etc. |
| Gram (+)<br>êµ¬ê· (cocci)                     | ![[Pasted image 20241022200325.png\|80]] | **Amoxicillin**, **Cephalospotin**<br>ìš°ì„ ì ìœ¼ë¡œ ê³ ë ¤ | Staphylococcus, Streptococcus,<br>Enterococcus, etc.     |

| ì•½ë¬¼ ì²˜ë°©                                                               |                                                                                                                             |
| ------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------- |
| **Amoxicillin**<br> (11-15mg/kg PO TID)                             | - ì˜ ì‚¬ìš©í•˜ëŠ” ì•½ë¬¼                                                                                                                 |
| **Trimethoprim-sulfamethoxazole**<br> (15mg/kg PO BID)              |                                                                                                                             |
| Amoxicillin clavulanate<br> (12.5-25mg/kg PO BID-TID)               |                                                                                                                             |
| **Cephalexin**<br> (15-30mg/kg PO BID)                              | - ì—¬ê¸°ê¹Œì§€ 4ê°œì˜ ì•½ë“¤ì€ Time-dependent.                                                                                              |
| **Enrofloxacin**<br> (5-20mg/kg PO SID dogs,<br>5mg/kg PO SID cats) | ì‹œê°„ë³´ë‹¤ëŠ” Dose-dependent, í•˜ë£¨ 1ë²ˆ ë³µìš©.<br>- ê³ ì–‘ì´ì—ì„œëŠ” ë…ì„±ì´ ìˆì–´ ê³ ë†ë„ ì‚¬ìš© X<br>- ì¹¨íˆ¬ë ¥ì´ ë›°ì–´ë‚¨ â†’ ì¬ë°œì„± ë°©ê´‘ì—¼ì—ì„œ í€´ë†€ë¡ ì œ ì¶”ì²œ.<br>   ë‹¨ ë‚´ì„±ì´ ì˜ ìƒê¸°ë‹ˆ, ê¼­ í•„ìš”í•  ë•Œë§Œ. |
%%
- **Amoxicillin** (11-15mg/kg PO TID) : ì˜ ì‚¬ìš©
- **Trimethoprim-sulfamethoxazole** (15mg/kg PO BID) : 
- Amoxicillin clavulanate (12.5-25mg/kg PO BID-TID)
- Enrofloxacin (5-20mg/kg PO): 1ë£¨ 1ë²ˆ ë³µìš© í€´ë†€ë¡  ì œì œ, ì¹¨íˆ¬ë ¥ì´ ë›°ì–´ë‚¨.
	- í€´ë†€ë¡  â†’ ë‚´ì„±ì´ ì˜ ìƒê¹€. uncomplicated ë”°ìœ„ì˜ ë³‘ì— ë„ˆë¬´ ë§‰ ì“°ë©´ ë‹¤ë¥¸ í•„ìš”í•œ ë³‘ì— ì“¸ ìˆ˜ ì—†ì„ì§€ë„.
%%

 
### âœ… Recurrent & Complicated Bacterial cystitis (ì¬ë°œì„± ë°©ê´‘ì—¼)
- ê¸°ì € ì§ˆí™˜ í™•ì¸ì´ ê°€ì¥ ì¤‘ìš”. 2ì£¼ ì •ë„ ì§€ì¼œë³´ë©° ì“°ê³ , ì¹˜ë£Œ ê¸°ê°„ì€ 4ì£¼ê¹Œì§€ ì¡ìŒ.
- í€´ë†€ë¡  ê³„ì—´ ì•½ë¬¼ì´ ì¡°ì§ ì¹¨íˆ¬ê°€ ì˜ ë¨ â†’ ì‹ ìš°ì‹ ì—¼, ì „ë¦½ì„ ì—¼ì— íš¨ê³¼ ì¢‹ìŒ. but ë‚´ì„± ì£¼ì˜í•˜ì—¬ ë‚¨ìš©í•˜ì§€ ì•Šë„ë¡ í•œë‹¤.
- ì¬ë°œì„± â†’ ì €í•­ì„± ê³ ë ¤í•˜ì—¬, monitoring ì‹œê¸°ë‚˜ ì¹˜ë£Œ ë°˜ì‘ ê¸°ê°„ì„ ê¸¸ê²Œ ë³¼ í•„ìš”ê°€ ìˆìŒ.
	- í•­ìƒì œ ì¹˜ë£Œ ì‹œì‘ í›„ 7ì¼, í•­ìƒì œ ì¹˜ë£Œ ì¢…ë£Œ í›„ 7ì¼, montly basis (3ë²ˆ ì •ë„)
- í•­ìƒì œë§Œìœ¼ë¡œ ì˜ ì•ˆ ë“£ëŠ” ê²½ìš°, ë³´ì¡° ìš”ë²•ì„ ì‚¬ìš©í•  ìˆ˜ ìˆìŒ.
	- 'ë³´ì¡° ìš”ë²•'ì¸ ë§Œí¼, <u>ë‹¨ë…ìœ¼ë¡œ ì¹˜ë£Œí•˜ê¸°ì—” ì ì ˆí•˜ì§€ ì•Šë‹¤</u>.

>[!note] ë³´ì¡°ì œ: ==Methenamine==
> - Methenamine mandelate, methenamine hippurate 
> - cyclic hydrocarbonìœ¼ë¡œ, ê°€ìˆ˜ë¶„í•´ë˜ì–´ ammoniaì™€ formaldehyde ìƒì„±
> - ë‡¨ë¥¼ ì‚°ì„±í™”í•˜ì—¬ ì„¸ê·  ì¦ì‹ì´ ì–´ë µê²Œ í•œë‹¤.
> - ë‹¨, ì†Œë³€ì´ ì‚°ì„±í™”ë˜ë©´ í•­ìƒì œ íš¨ê³¼ê°€ ê°ì†Œí•  ìˆ˜ ìˆë‹¤<br>: Fluoroquinolones, aminoglycoside (==gentamycin==, amikacin)

>[!note] ë³´ì¡°ì œ: ==Cranberry proanthocyanidins (PACs)==
>- ê°œë‚˜ ê³ ì–‘ì´ê°€ í¬ëœë² ë¦¬ ë§›ì„ ì¢‹ì•„í•˜ì§€ ì•Šì•„, íŒŒìš°ë” ì œì œë¡œ ì‚¬ìš©
>- ==ë°©ê´‘ì— ëŒ€ì¥ê· ì´ ë¶€ì°©í•˜ëŠ” ê²ƒì„ ì–µì œ==í•˜ëŠ” íš¨ê³¼ê°€ ìˆë‹¤.

### â“ Treatment failure
>[!danger] ì¹˜ë£Œ ì‹¤íŒ¨ì˜ ì´ìœ 
>- ë¶€ì ì ˆí•œ ì¹˜ë£Œ
>- Impaired action of drugs (ë³´í˜¸ìê°€ ì•½ì„ ì˜ ë¨¹ì´ì§€ ì•Šì•„ì„œ)
>	- ì • ì–´ë ¤ìš°ë©´ 2ì£¼ ì •ë„ ê°€ëŠ” ì£¼ì‚¬ ì œì œë¡œ êµì²´ ë“±
>- ë‚´ì„± ê· ì£¼, ê¸°ì € ì§ˆí™˜, ìœ„ì¥ê´€ ì§ˆí™˜ ë“±
>- **[[AMR (antimicrobial resistance)|AMR (antimicrobial resistance)]]** : í•­ìƒì œ ì €í•­ì„± ì‹¬ê°
>	- <u>MDR (Multidrug-resistant)</u> bacteria : 3ê°œ ì´ìƒì˜ í•­ìƒì œ ê³„ì—´ì—ì„œ ê°ìˆ˜ì„± ìˆìŒ. (í€´ë†€ë¡  ì œì œ ë“±)
>	- <u>XDR (Extensively drug-resistant)</u> bacteria : ê·¸ë³´ë‹¤ ë‚´ì„± íŒ¨í„´ì´ ë” ê°•í•¨. 1-2ê°œ ê³„ì—´ì—ì„œ ê°ìˆ˜ì„±.
>	- <u>PDR (Pandrug-resistant) bacteria</u> : ê°€ì¥ ì‹¬ê°, ê±°ì˜ ëª¨ë“  í•­ìƒì œê°€ íš¨ëŠ¥X (ê·¸ë˜ë„ ì‚¬ëŒì—ì„œë§Œí¼ ë§ì§€ëŠ” ì•ŠìŒ)


###  âœ… Pyelonephritis
- ì¹˜ë£Œ ê¸°ê°„ì€ 4-6ì£¼ ì •ë„ë¡œ ì¡ìŒ.
- **ì¡°ì§ ì¹¨íˆ¬ë ¥**ì´ ì¢‹ì€ í•­ìƒì œ ì‚¬ìš©
	- **Fluoroquinolones** : enrofloxacin, marbofloxacin, ciprofloxacin) - ë‚´ì„± ì£¼ì˜
	- ê·¸ ì™¸.. trimethoprim-sulfamethoxazole, amoxicillin, cefovecin ë“±
- ìˆ˜ì•¡ ì¡°ì¹˜ê°€ ì¹˜ë£Œì— ì¢‹ìŒ (ì´ë‡¨ë¥¼ ë„ì™€ì£¼ëŠ” ê²ƒ)
- ì†Œë³€ ì±„ì·¨ë¥¼ í†µí•œ ëª¨ë‹ˆí„°ë§ í•„ìš” (ì¹˜ë£Œ ì‹œì‘ í›„ 14ì¼ì§¸, ì¹˜ë£Œ ì¢…ë£Œ í›„ 7-14ì¼, ì´í›„ ë‹¬ë§ˆë‹¤ 3ë²ˆ)



### âœ… Bacterial prostatitis
- ì¹˜ë£Œ ê¸°ê°„ì€ ìµœì†Œ 4ì£¼.
- í•­ìƒì œ ì‚¬ìš©: ì‹ ìš°ì‹ ì—¼ë³´ë‹¤ ì¢€ ë” ì¡°ì§ ì¹¨íˆ¬ ì˜ ë˜ëŠ” ì•½ë¬¼ì´ ìš”êµ¬ë¨.
	- ì¡°ì§ ì¹¨íˆ¬ë ¥ ì¢‹ê³ , ë‹¨ë°±ì§ˆ ê²°í•© ì ê²Œ ë˜ê³ , ì´ì˜¨í™” ì˜ ë˜ëŠ” ì•½ë¬¼ (ì•„ë˜ 3ê°€ì§€ê°€ ëŒ€í‘œì )
	- Fluoroquinolones : **enrofloxacin** (ê°€ì¥ ë§ì´ ì‚¬ìš©) - ì•ˆ ë˜ë©´ marbofloxacin
	- **Trimethoprim-sulfamethoxazole**
	- **Chloramphenicol**
	- ê·¸ ì™¸.. amoxicillin, ampicillin, cephalosporines(cefovecin)
- ì ˆì œ(ì¤‘ì„±í™”)ê°€ ë” ê·¼ë³¸ì ì¸ ì¹˜ë£Œ 
- ì „ë¦½ì„ ì•¡ culture ì‹œ ì‹¤ì§ˆì´ ì„ì—¬ ìˆì„ ìˆ˜ ìˆìœ¼ë¯€ë¡œ, 


# 6. ì˜ˆí›„


|                       | + ì˜ˆí›„ ì¸ì                                                   | - ì˜ˆí›„ ì¸ì                                     |
| --------------------- | --------------------------------------------------------- | ------------------------------------------- |
| Cystitis              | - Most uncomplicated UTIs<br>- ì ì ˆí•œ ì¹˜ë£Œ â†’ Highly responsive | - Complicated UTIs<br>- ê¸°ì € ì›ì¸ì„ ì°¾ê±°ë‚˜ ê´€ë¦¬ ì–´ë ¤ìš¸ ë•Œ |
| Pyelonephritis        |                                                           | (ì¼ë°˜ì ìœ¼ë¡œ ì˜ˆí›„ ë‚˜ì¨)                               |
| Bacterial prostatitis | - í•­ìƒì œ ì˜ ì“°ë©´ ì˜ˆí›„ good<br>- ì¬ë°œ ì˜ˆë°©ì´ ì¤‘ìš”; ì¤‘ì„±í™” ê¶Œì¥                 |                                             |

# 7. ì˜ˆë°©
- **Catheterizaiton** ì‹œ ì˜ˆë°©ì  í•­ìƒì œ/ê°ì—¼ ëª¨ë‹ˆí„°ë§ (ì¬ë°œì„± UTI í™˜ìì—ì„œëŠ” ì¹´í…Œí„° ê¶Œì¥X)
- ì˜ˆë°©ì  í•­ìƒì œ ì²˜ë°©ì€ íš¨ê³¼ê°€ ë–¨ì–´ì§€ëŠ” í¸
- ì €ìš©ëŸ‰ í•­ìƒì œ ëŠìœ¼ë©´ ë°”ë¡œ ì¬ë°œ 
- ìœ ì‚°ê· (probiotics)
- ë‹¤ë‹¹ë¥˜ - D-mannose : ì„¸ê· ì˜ ë¶€ì°© ì–µì œ
- ë³´ì¡°ì œ - Cranberry extract, methenamine
- ì¤‘ì„±í™”(castration) : ì „ë¦½ì„ ì—¼ì˜ ê²½ìš° ê³ ë ¤